Home News & Events Events Events Page tools Share Share Share on LinkedinShare on BlueskyShare on XShare on Facebook Print Search Email Accessibility Filter events Filter events by clicking within the ‘Category’ drop-down list. Category - Any - Industry Webinars Workshop Industry AASLD Date 5 November 2026 - 9 November 2026 Time 08:00 - 18:00 Location Denver, CO, USA Timezone MDT - America/Denver ICON will exhibit | Booth #1861 Industry ISPOR EU Date 8 November 2026 - 11 November 2026 Time 08:00 - 18:00 Location Vienna, Austria Timezone Europe/Vienna ICON will exhibit Industry ISPOR EU 2026 Date 8 November 2026 - 11 November 2026 Time 08:00 - 18:00 Location Vienna, Austria Timezone Europe/Vienna Industry Obesity Week 2026 Date 14 November 2026 - 17 November 2026 Time 08:00 - 18:00 Location Washington DC, USA Timezone EDT - America/New York ICON will exhibit | Booth #212 Industry EBF Date 17 November 2026 - 19 November 2026 Time 08:00 - 18:00 Location Barcelona, Spain Timezone Europe/Madrid ICON will exhibit and speak Industry SCDM India Date 3 December 2026 - 5 December 2026 Time 08:00 - 18:00 Location Bengaluru, India Timezone IST - Asia/Kolkata ICON will exhibit and speak Previous 1 2 3 In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events ASCO 2026 ISPOR EU 2026 Webinars Workshops Webinars Social media hub Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information: Solutions Webinars Solutions Industry events Solutions Workshops What's happening in ICON ICON Plc Europe is emerging as an attractive route to global market access for Chinese sponsors. Early consideration of EMA requirements can help avoid costly delays and improve approval success. Read the article: https://ow.ly... 7 Aug View post View webpage ICON Plc Preparing for Italy's new serialisation framework requires more than regulatory awareness. Marketing authorisation holders, manufacturers and supply chain partners will need to assess packaging configurations, validate ... 6 Aug View post View webpage ICON Plc As biologics, biomarker-enriched trials and real-world evidence reshape the COPD landscape, sponsors face both new opportunities and increasing complexity. Success depends on translating these advances into effective cli... 5 Aug View post View webpage ICON Plc As biotech confidence returns and deal activity accelerates, companies have an opportunity to position themselves for the next phase of growth. In a new BioPharma Dive article, Deepali Suri, President of ICON Biotech, s... 5 Aug View post View webpage ICON Plc We are proud to share that ICON has been named a Winner for Organisational Excellence for the second year running at the GCC India Workplace Innovation Summit & Awards 2026. This recognition celebrates organisations red... 5 Aug View post View webpage ICON Plc Vaccines save millions of lives each year and help protect communities from preventable diseases. In support of National Immunisation Awareness Month, ICON is proud to have participated in 147 vaccine studies across key ... 4 Aug View post View webpage ICON Plc Heart failure affects millions of people worldwide and can significantly impact quality of life. Research into new treatment approaches remains critical to improving outcomes and expanding options for patients living wit... 3 Aug View post View webpage ICON Plc Colleagues at our Mexico office put their gaming skills to the test earlier this month at the ICON4U Super Smash Bros. Ultimate Tournament. Organised by the ICON4U Engagement and Celebrations Chapter, the event welcomed... 31 Jul View post ICON Plc ctDNA holds significant potential for accelerating cancer drug development, but acceptance as a primary surrogate endpoint remains a major regulatory challenge. ICON’s Bea Mann examines the scientific, regulatory and evi... 31 Jul View post View webpage ICON Plc Latest issue now available. Join thousands of subscribers who have discovered the convenience of our free monthly publication, by signing up today. https://ow.ly/hTYQ50Zu7sT Compiled and collated by ICON’s Regulatory I... 30 Jul View post View webpage ICON Plc Accelerated approval is not a shortcut – it is a strategic decision that demands robust planning. In this latest Drug & Device World article, ICON’s Elizabeth Madichie and Jack Martin highlight why surrogate endpoints m... 30 Jul View post View webpage ICON Plc With more than 70 COPD therapies in development, differentiation has never been more important. As development programmes become increasingly targeted, sponsors must integrate biomarker-informed strategies, patient-focu... 29 Jul View post View webpage
